Cargando…
Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome
Studies concerning the role of arachidonic acid (AA) and its metabolites in kidney disease are scarce, and this applies in particular to idiopathic nephrotic syndrome (INS). INS is one of the most frequent glomerular diseases in childhood; it is characterized by T-lymphocyte dysfunction, alterations...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196840/ https://www.ncbi.nlm.nih.gov/pubmed/34064238 http://dx.doi.org/10.3390/ijms22115452 |
_version_ | 1783706780147122176 |
---|---|
author | Turolo, Stefano Edefonti, Alberto Mazzocchi, Alessandra Syren, Marie Louise Morello, William Agostoni, Carlo Montini, Giovanni |
author_facet | Turolo, Stefano Edefonti, Alberto Mazzocchi, Alessandra Syren, Marie Louise Morello, William Agostoni, Carlo Montini, Giovanni |
author_sort | Turolo, Stefano |
collection | PubMed |
description | Studies concerning the role of arachidonic acid (AA) and its metabolites in kidney disease are scarce, and this applies in particular to idiopathic nephrotic syndrome (INS). INS is one of the most frequent glomerular diseases in childhood; it is characterized by T-lymphocyte dysfunction, alterations of pro- and anti-coagulant factor levels, and increased platelet count and aggregation, leading to thrombophilia. AA and its metabolites are involved in several biological processes. Herein, we describe the main fields where they may play a significant role, particularly as it pertains to their effects on the kidney and the mechanisms underlying INS. AA and its metabolites influence cell membrane fluidity and permeability, modulate platelet activity and coagulation, regulate lymphocyte activity and inflammation, preserve the permeability of the glomerular barrier, influence podocyte physiology, and play a role in renal fibrosis. We also provide suggestions regarding dietary measures that are able to prevent an imbalance between arachidonic acid and its parental compound linoleic acid, in order to counteract the inflammatory state which characterizes numerous kidney diseases. On this basis, studies of AA in kidney disease appear as an important field to explore, with possible relevant results at the biological, dietary, and pharmacological level, in the final perspective for AA to modulate INS clinical manifestations. |
format | Online Article Text |
id | pubmed-8196840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81968402021-06-13 Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome Turolo, Stefano Edefonti, Alberto Mazzocchi, Alessandra Syren, Marie Louise Morello, William Agostoni, Carlo Montini, Giovanni Int J Mol Sci Review Studies concerning the role of arachidonic acid (AA) and its metabolites in kidney disease are scarce, and this applies in particular to idiopathic nephrotic syndrome (INS). INS is one of the most frequent glomerular diseases in childhood; it is characterized by T-lymphocyte dysfunction, alterations of pro- and anti-coagulant factor levels, and increased platelet count and aggregation, leading to thrombophilia. AA and its metabolites are involved in several biological processes. Herein, we describe the main fields where they may play a significant role, particularly as it pertains to their effects on the kidney and the mechanisms underlying INS. AA and its metabolites influence cell membrane fluidity and permeability, modulate platelet activity and coagulation, regulate lymphocyte activity and inflammation, preserve the permeability of the glomerular barrier, influence podocyte physiology, and play a role in renal fibrosis. We also provide suggestions regarding dietary measures that are able to prevent an imbalance between arachidonic acid and its parental compound linoleic acid, in order to counteract the inflammatory state which characterizes numerous kidney diseases. On this basis, studies of AA in kidney disease appear as an important field to explore, with possible relevant results at the biological, dietary, and pharmacological level, in the final perspective for AA to modulate INS clinical manifestations. MDPI 2021-05-21 /pmc/articles/PMC8196840/ /pubmed/34064238 http://dx.doi.org/10.3390/ijms22115452 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Turolo, Stefano Edefonti, Alberto Mazzocchi, Alessandra Syren, Marie Louise Morello, William Agostoni, Carlo Montini, Giovanni Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome |
title | Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome |
title_full | Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome |
title_fullStr | Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome |
title_full_unstemmed | Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome |
title_short | Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome |
title_sort | role of arachidonic acid and its metabolites in the biological and clinical manifestations of idiopathic nephrotic syndrome |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196840/ https://www.ncbi.nlm.nih.gov/pubmed/34064238 http://dx.doi.org/10.3390/ijms22115452 |
work_keys_str_mv | AT turolostefano roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome AT edefontialberto roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome AT mazzocchialessandra roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome AT syrenmarielouise roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome AT morellowilliam roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome AT agostonicarlo roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome AT montinigiovanni roleofarachidonicacidanditsmetabolitesinthebiologicalandclinicalmanifestationsofidiopathicnephroticsyndrome |